Coretronic(5371) announced on the 21st that its subsidiary, Innospectra Co., Ltd will display the results of using near-infrared spectrometers developed by DLP technology to detect the authenticity of medicines at the “MQPH 2018 Seminar (Medicine Quality & Public Health 2018); "Handheld NIR spectroscopy" as a tool, combined with mobile phones, APP applications and drug databases, to identify the authenticity of malaria and tuberculosis drugs in third world countries.

Coretronic(5371) said that Innospectra develops a handheld near-infrared spectrometer based on DLP technology, greatly reducing hardware costs and selling prices, and also maintaining the same accuracy and stability as commercially available spectrometers, enabling near-infrared spectrometers to enter the application field of fast screening and expand the market scale.

In addition, because its sampling module has not only diffuse reflection type, but also optical fiber type and transmission type, it can be adjusted and applied to PAT (Process Analytical Technology) and Industry 4.0 fields according to requirements. Coretronic(5371) bluntly stated that the display of its products and achievements is an important milestone for global counterfeit drug detection technology and Innospectra Co., Ltd.

The MQPH 2018 S Seminar , to be held at the University of Oxford, UK, from September 23 to 28, 2018, is Is the first international conference on professional medicine and public health, and will provide an excellent opportunity for health authorities, scientists, pharmacists, lawyers, national regulators, and international organizations to discuss the issue of drug management and counterfeit medicines, and to outline the global treatment of counterfeit and Necessary procedures for non-conforming medical products.